Existing studies on SFN against NAFLD focused on inhibiting hepatic liposynthesis and steatosis [23,48], improving insulin resistance [21], antioxidant effects after NRF2 activation [49], and protecting mitochondrial functions [22]. The gene discussed is NFE2L2; the disease is steatosis.